Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

124 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study

NCT04400474

Conditions: Adenocarcinoma, Anaplastic Thyroid Cancer, Carcinoma, +11 more
Locations: Hospital Germans Trias i Pujol - ICO Badalona Badalona, Barcelona, Spain

Hospital Duran i Reynals - ICO L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain

Hospital General Universitario Elche Alicante, Spain

Hospital Universitari Vall d'Hebron Barcelona, Spain

View all 15 locations

View Trial Details

Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

UC Irvine Medical Center Orange, California, United States

University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

View all 71 locations

View Trial Details

Completed

A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer

NCT02795988

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations: ARENSIA Exploratory Medicine LLC Tbilisi, Georgia

City Cancer Center Vijayawada, Andhra Pradesh, India

North East Cancer Hospital and Research Institute Guwahati, Assam, India

Shetty's Hospital Bengaluru, Karnataka, India

View all 22 locations

View Trial Details

Completed

A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer

NCT01249352

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations: Hospital Evangélico do Cachoeiro do Itapemirim Cachoeiro de Itapemirim, Espírito Santo, Brazil

Hospital Universitário de Brasília Brasília, Federal District, Brazil

Santa Casa de Misericórdia de BH Belo Horizonte, Minas Gerais, Brazil

Hospital Erasto Gaetner Curitiba, Paraná, Brazil

View all 19 locations

View Trial Details

Completed

A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China

NCT05337163

Conditions: Actinomycetales Infections, Acute Bronchitis, Adenocarcinoma, +51 more
Locations: Nanfang Hospital of Southern Medccal University Guangzhou, Guangdong, China

View Trial Details

Completed

Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC

NCT00321048

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +9 more
Locations: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

NCT03535727

Conditions: Adenocarcinoma, Carcinoma, Digestive System Disease, +13 more
Locations: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

The Registry of Oncology Outcomes Associated With Testing and Treatment

NCT04028479

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
Locations: Teton Cancer Institute Idaho Falls, Idaho, United States

Oncology and Hematology of South Texas Laredo, Texas, United States

View Trial Details

Completed

Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)

NCT01393483

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

NCT04263090

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +17 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details